Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models Alexandre CorthayKatrin U. LundinBjarne Bogen Review 15 April 2004 Pages: 759 - 769
Expression of IAP family proteins in colon cancers from patients with different age groups T. EndoS. AbeK. Hirokawa Original Article 11 May 2004 Pages: 770 - 776
Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer E. Claire DeesKaren P. McKinnonJonathan S. Serody Original Article 08 June 2004 Pages: 777 - 785
Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer Haruko YamajiToshihiko IizasaTakehiko Fujisawa Original Article 04 June 2004 Pages: 786 - 792
Efficient generation of antileukemic autologous T cells by short-term culture and γ-irradiation of myeloid leukemic cells Rodolphe VereecqueAurore SaudemontBruno Quesnel Original Article 20 April 2004 Pages: 793 - 798
Activated vitronectin as a target for anticancer therapy with human antibodies Haiko J. BloemendalHetty C. de BoerEmile E. Voest Original Article 10 June 2004 Pages: 799 - 808
A phase I trial of idiotypic vaccination with HMFG1 in ovarian cancer Steve NicholsonC. C. BomphrayAndrew J. T. George Original Article 04 May 2004 Pages: 809 - 816
Proteasomal cleavage does not determine immunogenicity of gp100-derived peptides gp100209-217 and gp100209-217T210M Dirk NagorsenCatherine ServisFrédéric Lévy Original Article 05 May 2004 Pages: 817 - 824
Heat shock protein 70 / MAGE-1 tumor vaccine can enhance the potency of MAGE-1–specific cellular immune responses in vivo Jing YeGuang-Sheng ChenYan-Fang Sui Original Article 30 April 2004 Pages: 825 - 834
Monitoring the level of complement components during autologous blood stem cell transplantation in patients with malignant lymphomas Aniko BanyaiLilian VargaKatalin Paloczi Original Article 30 March 2004 Pages: 835 - 839
Immunotherapy with histamine and interleukin 2 in malignant melanoma with liver metastasis Sanjiv S. AgarwalaKristoffer HellstrandPeter Naredi Letter to the Editors 04 May 2004 Pages: 840 - 841